SAGE PRO

Home / Research / Aditya Infotech Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Aditya Infotech Limited — Q2 FY27 Results Analysis

Consolidated quarterly revenue nearly doubled

Published · Quarter Q2 FY27 · CPPLUS

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Q2 revenue

Q2 FY26₹919.6 crore
Q2 FY27₹1,746 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 2

H1 revenue

H1 FY26₹1,659.7 crore
H1 FY27₹3,148.4 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 3

Q2 EBITDA

Q2 FY26₹111.1 crore
Q2 FY27₹307.4 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 4

H1 EBITDA

H1 FY26₹176 crore
H1 FY27₹515.2 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Consolidated quarterly revenue nearly doubled

Quarter revenue is a strong starting point, not a cash-flow proxy

Watch: Check sell-through and receivables

RESEARCH INSIGHT

Six-month revenue growth confirms a broad half-year expansion

Compare the same half-year periods and accounting basis

Watch: Review H2 growth normalisation

RESEARCH INSIGHT

Q2 EBITDA outpaced revenue growth

The 17.6% margin is not management's H2 run rate

Watch: Stress test input costs

RESEARCH INSIGHT

H1 EBITDA reached ₹515.2 crore

The six-month result is more useful than a single quarter for the operating trajectory

Watch: Track second-half profitability

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Aditya Infotech Limited (NSE: CPPLUS) | Q2 and H1 FY2027 | Quarter ended 30 September 2026 | Consolidated, unaudited

Decision stance: WATCH. The quarter establishes unusually rapid revenue growth, a higher operating margin and stronger reported market positioning in Indian video surveillance. The crucial question is not whether Q2 was strong; it is how much of that performance can persist once input-cost protection, certified-camera demand and channel inventory normalise. The company itself cautioned that Q2's 17.6% EBITDA margin should not be treated as the second-half run rate. [S1][S2]

Decision metricQ2 FY27Q2 FY26Interpretation
Consolidated revenue (₹ crore)1,746.0919.6+89.9% YoY
EBITDA (₹ crore)307.4111.1+176.7% YoY
EBITDA margin17.6%12.0%+552 basis points
PAT before exceptional item (₹ crore)219.970.0+214.2% YoY; management's adjusted measure
Reported PAT (₹ crore)185.570.0+165.1% YoY; includes ₹34.4 crore fire loss

The comparison above uses the same consolidated accounting basis for each period. The investor presentation defines gross margin on revenue and other margins on total income; these denominators should not be silently interchanged. [S2]

Six investor takeaways

  • Growth: Q2 revenue reached ₹1,746.0 crore versus ₹919.6 crore; H1 revenue was ₹3,148.4 crore versus ₹1,659.7 crore. The quarter and half-year growth rates are both approximately 90%, reducing the risk that a single quarter alone explains the acceleration. [S2]
  • Profitability: Q2 EBITDA margin rose to 17.6% from 12.0%; H1 margin reached 16.3% from 10.6%. Management nevertheless retained full-year EBITDA margin guidance of 14–15%, explicitly expecting second-half moderation. Guidance is not a reported result. [S1][S2]
  • Quality of earnings: Q2 reported PAT of ₹185.5 crore is below pre-exceptional PAT of ₹219.9 crore because of a ₹34.4 crore fire-loss item at AIL Dixon. Investors should follow the insurance claim rather than treating recovery as cash already received. [S1][S2]
  • Product mix: IP products increased to about 79% of the CP PLUS portfolio from 71%; CP PLUS contributed roughly 88% of group Q2 revenue versus 86% a year earlier. This supports a mix-improvement thesis, but segment-level profit contribution is not separately quantified in the cited material. [S1]
  • Capital: At 30 September cash and equivalents were ₹1,433.9 crore and borrowings ₹362.7 crore, producing ₹1,071.2 crore net cash. This followed a ₹1,500 crore QIP, so it is not evidence that operations generated the entire net-cash increase. [S1][S2]
  • Cash discipline: Receivable days fell to 96 for H1 FY27 from 121 in FY26, but inventory days rose to 111 from 95. The resulting cash conversion cycle was 72 days versus 78; the improvement is real on this disclosed measure, but inventory and operating cash conversion need separate monitoring. [S2]

Investment decision rule. Without a contemporaneous share price, enterprise value, share count and consistent forward earnings bridge in these two sources, no numeric target price or fair-value multiple is asserted. A premium valuation would require evidence that market-share gains survive a lower margin environment, inventory unwinds without discounting, and planned capacity generates acceptable cash returns. A cheaper headline multiple would not compensate for a structural decline in returns on new manufacturing capital. The separate chart briefing below is a source-backed diagnostic, not a price forecast.

Chapter 1 — Investor decision, valuation discipline and what matters now

The central investment debate is whether CP PLUS has built a defensible advantage in India's newly certified surveillance-camera market or is enjoying a temporary period of unusually favourable pricing, demand and stock availability. The issuer attributes its leadership to certified products, in-house manufacturing, own firmware, distribution breadth and its established brand.

The presentation estimates around 42% share of the Indian video-surveillance market in the trailing 12 months to September 2026, compared with approximately 30% at its FY25 IPO reference point. These are company estimates, not an independently reconstructed market-share series. [S2]

The operating evidence is compelling: revenue almost doubled, EBITDA grew substantially faster, and CP PLUS's contribution to group revenue rose. Yet the call contains an equally important caution. Management said component and input costs are volatile, that it had protected channels from abrupt price increases, and that the unusually high Q2 margin should not be annualised. Its unchanged 14–15% full-year margin guidance is a deliberate counterweight to the 17.6% quarterly outcome. [S1]

For an investor, the correct question is whether certified-product leadership can generate attractive *through-cycle* returns after distributor incentives, future price adjustments and manufacturing expansion. The QIP makes funding less constrained but introduces a second test: capital deployment must be productive, not simply large. Cash on the balance sheet should not be mistaken for recurring operating cash flow.

Decision takeaways

  • Treat 17.6% Q2 EBITDA margin as an observed peak-quarter result, not a base-case annual assumption. [S1][S2]
  • Use the disclosed 14–15% full-year margin guidance only as management's expectation, not as independently assured performance. [S1]
  • Verify that the claimed roughly 42% market share converts into repeat sell-through, not merely channel inventory. [S2]
  • Withhold a numerical valuation conclusion until current market price, diluted capital base and sustainable earnings/cash conversion are reconciled.

Chapter 2 — Reported quarter, H1 bridge and earnings quality

The consolidated financial table provides unusually clean same-period comparisons. Q2 revenue of ₹1,746.0 crore compares with ₹919.6 crore in Q2 FY26, while H1 revenue of ₹3,148.4 crore compares with ₹1,659.7 crore in H1 FY26. EBITDA was ₹307.4 crore against ₹111.1 crore in Q2 and ₹515.2 crore against ₹176.0 crore in H1. EBITDA margin advanced by 552 basis points in Q2 and 576 basis points in H1 according to the issuer's detailed table. [S2]

The gross-profit bridge helps identify where operating leverage is coming from. Q2 gross profit was ₹524.3 crore versus ₹274.0 crore, while gross margin was 30.0% versus 29.8%: only a modest 24-basis-point improvement. In contrast, H1 gross margin improved to 30.4% from 26.6%, a much larger 374-basis-point increase.

These are different time windows; it would be misleading to use H1's margin expansion as if it described Q2 alone. Employee costs increased to ₹124.9 crore from ₹82.9 crore in Q2, and other expenses to ₹96.0 crore from ₹82.5 crore, but revenue grew faster. [S2]

The earnings-quality distinction is essential. Q2 profit before tax before exceptional items was ₹286.2 crore versus ₹93.5 crore; after the ₹34.4 crore exceptional fire loss, reported PBT was ₹251.9 crore. The presentation reports Q2 PAT before the exceptional item at ₹219.9 crore and reported PAT at ₹185.5 crore.

H1 PAT before exceptional items was ₹362.1 crore versus ₹102.9 crore; reported H1 PAT was ₹327.7 crore. The fire-loss event occurred at AIL Dixon's Kadapa facility. Management said insurance covers the loss and a claim was lodged, but the filing excerpts do not establish a received cash reimbursement. [S1][S2]

The cost of debt is another useful bridge: Q2 finance costs declined to ₹6.0 crore from ₹6.9 crore, and H1 finance costs to ₹10.3 crore from ₹17.4 crore. Management indicated that October debt repayment would further affect the second half; that prospective effect is not included in the September-end balance sheet. H1 annualised ROCE of 34.3% versus 20.4% in H1 FY26 is encouraging, but a six-month annualisation is not the same as a full-cycle return. [S1][S2]

Financial takeaways

  • Q2 reported PAT growth (+165.1%) is materially below pre-exceptional PAT growth (+214.2%); never label the latter as statutory earnings growth. [S2]
  • The modest Q2 gross-margin movement alongside the large EBITDA-margin improvement requires attention to operating leverage and expense timing. [S2]
  • H1 revenue and EBITDA both grew faster than their respective prior-year bases, but the management outlook explicitly contemplates lower H2 margins. [S1]
  • Insurance recoverability and timing remain cash-flow monitoring items, not realised profit assumptions.

Chapter 3 — Product, channel and manufacturing economics

CP PLUS remains the group engine. Management said the brand accounted for approximately 88% of Q2 revenue, up from 86% a year earlier. Within CP PLUS, internet-protocol products were about 79% of the portfolio, compared with 71% earlier. These percentages refer to different denominators—brand share of group revenue and IP share within the CP PLUS portfolio—and must not be added or treated as two segments of a single mix chart. [S1]

The regulatory transition toward security-certified cameras changed the competitive environment. The presentation notes that OEMs could sell only certified cameras from April 2025 and that the sell-off of uncertified inventory ended in March 2026. The issuer says more than 100 CP PLUS models are STQC security-certified and that its manufacturing footprint can produce 2.5 million units per month. These are capability and compliance claims, not proof that all capacity is currently utilised or that every unit sold carries equal margin. [S2]

Distribution breadth supports the company's claim to leadership. In the call, management described roughly 30,000–35,000 installers and resellers connected to its incentive app and another 2,000 system integrators or installers engaged in projects. These counts describe relationships or reach, not verified active monthly purchasers. A broader installed and installer base could lower customer-acquisition friction, but channel stocking and receivable quality must be monitored as growth scales. [S1]

The secondary brands serve different price points. Management said NEXIVUE was gaining traction in the entry-to-mid segment, whereas EYRA had not yet meaningfully scaled. CP PLUS PRO is positioned for enterprise use. No comparable revenue or profit breakdown for EYRA, NEXIVUE or CP PLUS PRO was established in the selected source windows, so allocating group EBITDA to them would be invented precision. [S1]

Business-model takeaways

  • Certified supply, local manufacturing and distribution reach may reinforce one another; validate with market-share and sell-through evidence. [S1][S2]
  • Product mix is shifting toward IP cameras, but margin attribution by product is not disclosed in the cited tables. [S1]
  • Secondary brands offer potential reach into lower-price categories but are not yet a demonstrated independent earnings engine. [S1]
  • Monitor whether installer reach translates into collections and repeat orders rather than channel accumulation.

Chapter 4 — Execution, capital projects and management's Q&A

The ₹1,500 crore QIP is the pivot from a strong trading period to a capital-allocation test. The presentation states ₹1,465.5 crore net proceeds, with intended allocations of ₹325 crore toward repayment or prepayment of AIL and AIL Dixon borrowings, ₹650 crore for Kadapa Phase III and the Knowledge Park manufacturing plant, and ₹490.5 crore for acquisitions and general corporate purposes. These are allocations from the placement document, not proof that every project rupee has been spent. [S2]

Management said additional land of about 22 acres had been acquired for Kadapa Phase III and that land acquisition at Greater Noida was complete, with civil construction expected to begin subsequently. It indicated that capacity additions might come on line over 18–24 months, with a broader objective of roughly doubling capacity around late FY2029 to early FY2030. Those dates and the doubling ambition are forward-looking management statements, not current operating output. [S1]

The company also signed agreements dated 5 November 2026 for a ₹45.4 crore investment for a 30% fully diluted stake in BLUE KGraph AI Solutions, a video-compression technology business. Management described potential reductions of up to 90% in storage and bandwidth under relevant conditions, and a possible recurring software layer on the installed camera base.

Neither realised revenue from the stake nor a quantified payback period was provided in the selected evidence. The commercial value of this investment should therefore be judged on deployments and monetisation rather than headline technology claims. [S1][S2]

The analyst exchange raised useful constraints. On recorder certification, management explicitly said no new government notification had yet been issued for DVR/NVR products and would not quantify the impact until policy became clear. On the housing plant, it said expenditure had already occurred but could not provide a figure during the call. On working capital, management defended strategic inventory stocking while acknowledging that very rapid growth absorbs operating cash. These are genuine open monitoring questions rather than gaps to fill with estimates. [S1]

Execution takeaways

  • Separate committed QIP allocations from actual capex paid and capacity commissioned. [S2]
  • Track Kadapa and Greater Noida milestones against the stated 18–24 month phasing, not just project announcements. [S1]
  • Treat BLUE's compression potential as an engineering claim until customer deployments and financial contribution are disclosed. [S1][S2]
  • Do not price in a DVR/NVR regulatory windfall before a formal rule is notified. [S1]

Chapter 5 — Cash conversion, borrowings, capex and payback discipline

At 30 September 2026, consolidated cash and cash equivalents were ₹1,433.9 crore, total borrowings ₹362.7 crore, and net cash ₹1,071.2 crore. The presentation compares this with approximately ₹52 crore net cash at March 2026, but the intervening ₹1,500 crore QIP is a major financing inflow. The increase cannot be presented as internally generated cash. Management stated in the 6 November call that remaining borrowings were repaid in October; that is a post-balance-sheet statement, not the September-end borrowing number. [S1][S2]

Working-capital data show mixed signals. H1 FY27 receivable days were 96, compared with 121 for FY26, while inventory days were 111 versus 95. Payable days were 135 versus 138. The disclosed cash conversion cycle was 72 days versus 78. A six-day improvement in the cycle is helpful, but it coexists with a 16-day inventory build. Management attributed inventory positioning partly to strategic component purchasing and supply protection, and said that growth near 90% absorbs operating cash. [S1][S2]

The company also reports 34.3% annualised H1 ROCE and 26.9% annualised H1 ROE. Those return ratios reflect a period spanning a significant capital raise and should not be mechanically projected onto a much larger future asset base. The investment case needs a project-by-project return bridge once the ₹650 crore planned manufacturing allocation becomes productive. [S2]

The cited sources do not establish a reliable period cash-flow-statement reconciliation sufficient to quote precise H1 operating cash flow, free cash flow or capex cash paid here. Inventing those numbers would undermine the thesis. A rigorous next-quarter check should reconcile cash generated from operations, movement in inventories and trade receivables, project advances, and cash capex against management's growth narrative.

Capital and cash takeaways

  • Distinguish the September-end ₹362.7 crore borrowings from management's subsequent October repayment claim. [S1][S2]
  • The ₹1,071.2 crore net-cash position benefits from financing; it is not a substitute for cash conversion. [S2]
  • Receivable-day improvement and inventory-day deterioration need to be read together, not selectively. [S2]
  • Require commissioning, utilisation and return evidence before assigning value to future manufacturing capacity.

Chapter 6 — Conditional outcomes, risks and falsifiers

Bull case — leadership becomes structurally profitable. Certified-camera adoption remains durable, CP PLUS maintains a meaningful share advantage, IP mix continues to improve and distribution scales without looser credit. Gross margins and cash conversion remain resilient even if the exceptional Q2 EBITDA margin moderates. Kadapa and Greater Noida capacity comes online in line with management's milestones, and BLUE produces identifiable customer benefits. This case would be supported by stable receivable days, an inventory unwind and disclosed returns on commissioned assets—not merely by more revenue growth. [S1][S2]

Base case — growth normalises while the franchise remains strong. The regulatory step-change is largely absorbed, channel growth slows from Q2's near-90% pace, and EBITDA margin moves toward the 14–15% full-year range guided by management. The business still benefits from a larger installed base and broader manufacturing footprint, but returns on incremental capital take time to prove. This is a conditional framing, not a financial forecast; no rupee earnings or valuation estimate is assigned. [S1]

Bear case — volume leadership masks deteriorating cash economics. Input costs rise, price increases lag, distributors hold excess inventory, or receivable days reverse. New plants add depreciation and working capital before meaningful utilisation, while the smaller brands compete more on price. The result could be lower margins and cash returns even if reported sales remain high. A further downside would be a delayed insurance recovery or poorly monetised acquisition spending. These are identified risk mechanisms, not predictions of specific losses.

Falsifiers and evidence thresholds

  • A sustained reversal in receivable days toward the FY26 level of 121 would challenge the improved-collections narrative. [S2]
  • Persistent inventory days above the disclosed 111 without stronger sell-through would weaken the cash-conversion thesis. [S2]
  • Management reiterating 14–15% guidance despite a 17.6% Q2 margin is a reason to test H2 margins explicitly. [S1]
  • Slippage in the planned capacity timetable or unclear cash returns on the ₹650 crore allocation would challenge the capital-efficiency case. [S1][S2]
  • An adverse shift in certified-camera regulations or more intense price competition would weaken the claimed market-share moat. [S1][S2]

No target price, terminal growth rate, share-price return or future EPS is supplied because the selected filings do not establish a defensible full valuation model.

Chapter 7 — Action plan and quarterly monitoring dashboard

Current action: WATCH, with evidence-led review after the next results. The business has strong reported growth and profitability, but the two biggest underwriting uncertainties are sustainable post-transition margin and cash generation after a large capital raise. The next report should resolve those uncertainties before a higher-conviction investment decision.

Monitoring testCurrent issuer referenceWhat would change the assessment
Revenue durabilityQ2 ₹1,746.0 crore; H1 ₹3,148.4 croreGrowth supported by sell-through and stable receivables, not stock loading
EBITDA marginQ2 17.6%; H1 16.3%; FY27 guidance 14–15%H2 actual margin and explanation of input-cost effects
Statutory versus adjusted PATQ2 ₹185.5 crore reported; ₹219.9 crore before fire lossInsurance recovery and no recurring exceptional adjustments
Inventory disciplineH1 111 inventory days; FY26 95Stock normalisation without channel discounting
ReceivablesH1 96 days; FY26 121Sustained collections despite new brand/channel expansion
Cash and borrowingsSep net cash ₹1,071.2 crore; Oct repayment claimedReconciled operating cash flow and capex cash paid
Manufacturing investment₹650 crore intended QIP capex allocationCommissioned capacity, utilisation and measured returns
Product/market positionIP share ~79%; issuer-estimated market share ~42%Retention of certified-product leadership and improved unit economics

Next-quarter work plan

  • Obtain actual H2 gross margin, EBITDA margin and price/mix commentary to test management's warning against extrapolating Q2. [S1]
  • Compare reported PAT with any adjusted presentation and independently track the Kadapa fire insurance claim's status. [S1][S2]
  • Reconcile cash flow from operations to the working-capital movement, particularly inventory and trade receivables. [S1][S2]
  • Track Kadapa Phase III and Greater Noida milestones, capex incurred and incremental capacity brought into service. [S1]
  • Ask for commercial adoption metrics for NEXIVUE, EYRA and the BLUE compression investment rather than assuming all initiatives are profitable. [S1]
  • Monitor any actual notification governing DVR/NVR certification rather than extrapolating unannounced policy. [S1]

Research limits that matter: The issuer's own market-share estimate is not independently validated here; product-level profit margins, a reconciled operating cash-flow statement, detailed project paybacks, current share valuation and insurance cash receipts are not established in the two cited documents. Management outlook is identified as such. These omissions affect the investment decision and are not replaced with assumed numbers.

Original issuer/exchange sources

All financial amounts above are in Indian rupees crore unless otherwise specified. The financial tables are consolidated and unaudited; references to guidance, market-share estimates and project timelines are explicitly management statements.

Additional company evidence

CHART 5

Q2 EBITDA margin

Q2 FY2612%
Q2 FY2717.6%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 6

H1 gross margin

H1 FY2626.6%
H1 FY2730.4%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 7

Q2 gross margin

Q2 FY2629.8%
Q2 FY2730%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

CHART 8

Q2 reported PAT

Q2 FY26₹70 crore
Q2 FY27₹185.5 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.